124 related articles for article (PubMed ID: 4553652)
1. Inhibition of peptic activity in man by carbenoxolyne sodium.
Berstad A
Scand J Gastroenterol; 1972; 7(2):129-35. PubMed ID: 4553652
[No Abstract] [Full Text] [Related]
2. Inhibition of peptic activity by carbenoxolone and glycyrrhetinic acid.
Henman FD
Gut; 1970 Apr; 11(4):344-51. PubMed ID: 4913800
[TBL] [Abstract][Full Text] [Related]
3. Proceedings: Initial observations on the inhibitory action of urogastrone on gastric secretory responses in man.
Gillespie IE; Elder JB; Ganguli PC; Gregory H; Gerring L
Gut; 1974 Apr; 15(4):337. PubMed ID: 4151866
[No Abstract] [Full Text] [Related]
4. The inhibition by carbenoxolone sodium of individual human pepsinogens and pepsins.
Roberts NB; Taylor WH
Clin Sci; 1973 Feb; 44(2):6P-7P passim. PubMed ID: 4579239
[No Abstract] [Full Text] [Related]
5. Effect of carbenoxolone-sodium on blood pressure, plasma-renin activity and serum electrolytes in adrenalectomized patients.
Werning C; Bayer JM; Fischer N; Schweikert HU; Siegenthaler W
Dtsch Med Wochenschr; 1972 Jan; 97(3):91-2. PubMed ID: 5008088
[No Abstract] [Full Text] [Related]
6. [Experimental and clinical studies on the action mechanism of carbenoxolone. I. Influence of carbenoxolone on the gastric juice and mucus secretion in the rat].
Gheorghiu T; Frotz H; Klein HJ
Verh Dtsch Ges Inn Med; 1971; 77():511-5. PubMed ID: 5155883
[No Abstract] [Full Text] [Related]
7. Reproducibility of plasma gastrin concentration and gastric pepsin output after insulin-induced hypoglycaemia.
Elder JB; Walker DI; Ganguli PC; Gillespie IE
Scand J Gastroenterol; 1974 Nov; 9(8):731-4. PubMed ID: 4610715
[No Abstract] [Full Text] [Related]
8. Somatostatin and the gastrointestinal tract.
Arnold R; Lankisch PG
Clin Gastroenterol; 1980 Sep; 9(3):733-53. PubMed ID: 6107192
[No Abstract] [Full Text] [Related]
9. The effect of cigarette smoking on human gastric secretion.
Whitecross DP; Clarke AD; Piper DW
Scand J Gastroenterol; 1974; 9(4):399-403. PubMed ID: 4605237
[No Abstract] [Full Text] [Related]
10. Mechanism of the antipeptic action of amylopectin sulfate (SN-263), and antiulcer, mucin-like agent.
Cammarata PS; Bianchi RG; Fago FJ
Gastroenterology; 1971 Dec; 61(6):850-7. PubMed ID: 4942261
[No Abstract] [Full Text] [Related]
11. New therapeutic agents for peptic ulcer.
Augur NA
J Maine Med Assoc; 1971 Oct; 62(10):245-6 passim. PubMed ID: 4937792
[No Abstract] [Full Text] [Related]
12. [Experimental and clinical studies on carbenoxolone action mechanism. 3. Influence of carbenoxolone on gastric mucus secretion in man].
Gheorghiu T; Frotz H; Klein HJ
Verh Dtsch Ges Inn Med; 1972; 78():1415-8. PubMed ID: 4665567
[No Abstract] [Full Text] [Related]
13. Physiological control of gastric acid secretion.
Baron JH
Proc R Soc Med; 1971 Jul; 64(7):739-41. PubMed ID: 4934245
[No Abstract] [Full Text] [Related]
14. Pepsins, peptic activity, and peptic inhibitors.
Samloff IM
J Clin Gastroenterol; 1981; 3(Suppl 2):91-4. PubMed ID: 6119339
[TBL] [Abstract][Full Text] [Related]
15. The effect of tetragastrin on gastric acid secretion. Reproducibility and comparison with the pentagastrin test and the augmented histamine test.
Hart Hansen O; Madsen P
Scand J Gastroenterol; 1972; 7(2):171-5. PubMed ID: 5021063
[No Abstract] [Full Text] [Related]
16. Mucosal protective effects of ecabet sodium: pepsin inhibition and interaction with mucus.
Pearson JP; Roberts NB
Clin Sci (Lond); 2001 Apr; 100(4):411-7. PubMed ID: 11256980
[TBL] [Abstract][Full Text] [Related]
17. The potency of gastrin and related peptides to enhance the gastric secretory response to sham feeding.
Sjödin L
Scand J Gastroenterol; 1972; 7(2):145-9. PubMed ID: 4623208
[No Abstract] [Full Text] [Related]
18. [Antibiotics as proteolysis inhibitors in the stomach].
Gorshkov VA; Kudriashova GP; Anakina OE
Klin Med (Mosk); 1990 Aug; 68(8):83-5. PubMed ID: 2084381
[TBL] [Abstract][Full Text] [Related]
19. [Therapy of peptic ulcer and its perspectives].
Jirásek V
Cesk Gastroenterol Vyz; 1971 Jun; 25(4):155-63. PubMed ID: 4327638
[No Abstract] [Full Text] [Related]
20. Persistent inhibition of gastric secretion by an intravenous 12-hour infusion of calcitonin in normals, peptic ulcer and high risk patients.
Hotz J; Goebell H; Minne H; Ziegler R
Digestion; 1974; 11(3-4):311-4. PubMed ID: 4615022
[No Abstract] [Full Text] [Related]
[Next] [New Search]
